{"database": "lobbying", "table": "lobbying_activities", "rows": [[1180936, "16b31231-4c17-4d4e-8a01-d09f22fbc1f9", "Q4", "RED+BLUE STRATEGIES", 400693064, "EXPRESS SCRIPTS INC.", 2011, "fourth_quarter", "HCR", "Implementation of the Health Reform Law with a focus on regulations related to the medical loss ratio (MLR), Accountable Care Organizations, Transparency, E-prescribing,  Health Information Technology, and Essential Health Benefits.\n\nP.L. 112-25-Budget Control Act of 2011 Monitoring potential health-related offsets that could be included in related negotiations. Issues related to pathways for biogenerics in both domestic and international arenas.\n\nProposed OPM-focused policies in the Administration's 2012 Budget related to the utilization of Pharmacy Benefit Managers.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 30000, null, 0, 0, "2011-12-27T11:30:46-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1180936"], "units": {}, "query_ms": 0.29919203370809555, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}